Navigation Links
Peter J. McGuire, MB BCh, is awarded the 2008-2009 Genzyme/ACMGF Clinical Genetics Fellowship
Date:4/2/2008

Peter J. McGuire, MB BCh, of Mount Sinai Medical Center, New York was honored as the 2008-2009 recipient of the Genzyme/ACMGF Clinical Genetics Fellowship in Biochemical Genetics at the ACMG 2008 Annual Clinical Genetics Meeting in Phoenix, AZ.

The objective of the Genzyme/ACMGF Award is to support a national fellowship program to encourage the recruitment and training of clinicians in the field of clinical biochemical genetics and especially in the diagnosis, management and treatment of individuals with metabolic diseases. This award grants $75,000 per year and will provide for the sponsorship of a trainees first year of fellowship following residency in a genetics fellowship on biochemical genetic diseases.

The Genzyme/ACMGF Clinical Genetics Fellowship in Biochemical Genetics is especially important at this point in history as we work together to increase the genetics workforce and to advance education, research and standards of practice in medical genetics in the United States. said R. Rodney Howell, MD, FACMG, president of the ACMGF.


'/>"/>

Contact: Kathy Ridgely Beal
kbeal@acmg.net
301-238-4582
American College of Medical Genetics
Source:Eurekalert

Page: 1

Related biology news :

1. Harold Mooney and Peter Raven, winners of the BBVA Foundation Award for Conservation Biology
2. UM coral scientist Peter Glynn wins award for scholarly activity
3. 12 McGill researchers awarded Canada Research Chairs
4. Anthony S. Fauci awarded Lasker Award for Public Service
5. ETH Zurich professor Ari Helenius awarded Benoist Prize
6. Nanobiosym awarded $2 million DTRA contract
7. Mustafa alAbsi Ph.D. and national team awarded major NIH grant
8. Parus Interactive Awarded Patent for Speech-Activated Remote System Management
9. $2.7 million awarded for metastatic colon cancer research
10. UCR researchers awarded nearly $1.7M to develop improved cowpea varieties
11. BIO-key(R) and Tiger IT Awarded a Follow-on Contract for Nationwide Voter / Citizen Registration in Bangladesh
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2017)... 2017 Research and Markets has ... Medicine - Scientific and Commercial Aspects" to their offering. ... ... integrated with therapy for selection of treatment as well for ... prevention of disease in modern medicine. Biochip/microarray technologies and next ...
(Date:2/8/2017)... YORK , Feb. 7, 2017 Report Highlights ... The ... should reach $11.4 billion by 2021, growing at a compound ... Includes - An overview of the global markets for synthetic ... 2015, estimates for 2016, and projections of compound annual growth ...
(Date:2/7/2017)... Ind. , Feb. 7, 2017 Zimmer ... leader in musculoskeletal healthcare, will present at the LEERINK ... New York Palace Hotel on Wednesday, February 15, 2017 ... live webcast of the presentation can be accessed at ... replay following the conference via Zimmer Biomet,s Investor Relations ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... , Feb. 24, 2017  OncoSec Medical Incorporated ... immunotherapies, will host a Key Opinion Leader event to ... an oral and poster presentation at the upcoming 2017 ... The KOL event will be held in-person and via ... EST / 9:00 AM PST at the Lotte New ...
(Date:2/23/2017)... Calif. , Feb. 23, 2017  MIODx ... license for two key immunotherapy technologies from the ... technology provides a method to monitor a patient ... as PD-L1 and CTLA-4.  The second license extends ... a patient is likely to have an immune-related ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... that in a published evaluation of multiple immunoassay-based threat detection technologies by ... Energy Laboratory, PathSensors’ CANARY® biosensor threat detection technology was found to have ...
(Date:2/23/2017)... Feb. 23, 2017 Aviva Systems Biology ... the acquisition of GenWay Biotech Incorporated, a protein ... and product offering for both the research and ... growth and enhance capabilities for both entities. GenWay,s 18 ... assays will nicely complement ASB,s objective to become ...
Breaking Biology Technology: